GABPAP: A Transcription Factor Regulating Cell Proliferation and Disease

Target Name: GABPAP

NCBI ID: G8327

GABPAP

Other Name(s): GA binding protein transcription factor, alpha subunit pseudogene | E4TF1B | GABPA pseudogene | E4TF1 | GABPB1

GABPAP: A Transcription Factor Regulating Cell Proliferation and Disease

GABPAP, also known as GA binding protein transcription factor, alpha subunit pseudogene, is a protein that plays a crucial role in gene expression and cell biology. It is a transcription factor that binds to the GA site, which is a unique base-pair combination found in the gene promoter region that is responsible for regulating gene expression. GABPAP is a key regulator of cell proliferation and has been implicated in a variety of diseases, including cancer, neurodegenerative diseases, and developmental disorders.

GABPAP is a protein that is expressed in most tissues of the body and is highly conserved across species. It is a nuclear protein that is primarily localized to the cytoplasm, where it can interact with various cellular components to regulate gene expression. GABPAP has four known functions, including promoting cell proliferation, enhancing the expression of neuronal genes, regulating the expression of immune genes, and modulating the expression of genes involved in cell adhesion and migration.

GABPAP is a key regulator of cell proliferation and has been shown to play a role in the regulation of cell cycle progression. It is well known that the GABPAP gene is highly expressed in cancer cells and that it is involved in the regulation of cell cycle progression, apoptosis, and sensitivity to chemotherapy. Several studies have shown that GABPAP can inhibit the activity of the cyclin D1 enzyme, which is involved in the regulation of cell cycle progression. This inhibition leads to the accumulation of GABPAP in the cells, which can then induce the expression of genes involved in cell cycle progression inhibition, leading to the inhibition of cell proliferation.

GABPAP is also involved in the regulation of neurodegenerative diseases. There is significant evidence to suggest that GABPAP is involved in the development and progression of neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease. GABPAP has been shown to interact with various neurotransmitters, including dopamine, and to regulate the expression of genes involved in neurotransmitter synthesis and release. Additionally, GABPAP has been shown to play a role in modulating the expression of genes involved in neuroprotective enzymes, such as superoxide dismutase and antioxidant enzymes.

GABPAP is also involved in the regulation of developmental disorders. GABPAP has been shown to play a role in the regulation of development and growth, including the regulation of neuronal differentiation and plasticity. GABPAP has been shown to interact with various signaling pathways, including TGF-β and Wnt, and to regulate the expression of genes involved in neuronal development and plasticity.

In conclusion, GABPAP is a protein that plays a crucial role in gene expression and cell biology. It is a transcription factor that binds to the GA site and is involved in the regulation of cell proliferation, neurodegenerative diseases, and developmental disorders. GABPAP is a potential drug target and may be a valuable biomarker for the diagnosis and treatment of various diseases. Further research is needed to fully understand the role of GABPAP in gene expression and disease.

Protein Name: GABPA Pseudogene

The "GABPAP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GABPAP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets